INTERNATIONAL PATENT: PRILENIA THERAPEUTICS INC. FILES APPLICATION FOR "COMBINATION OF PRIDOPIDINE AND LOW DOSE ANTI-DOPAMINERGIC MEDICATION (ADM) FOR TREATING HUNTINGTON DISEASE AND SYMPTO THEREOF"

GENEVA, Feb. 18 -- PRILENIA THERAPEUTICS INC. (300 Fifth Avenue, Suite 5010Waltham, Massachusetts 02451) filed a patent application (PCT/US2025/041106) for "COMBINATION OF PRIDOPIDINE AND LOW DOSE ANTI-DOPAMINERGIC MEDICATION (ADM) FOR TREATING HUNTINGTON DISEASE AND SYMPTO THEREOF" on Aug 07, 2025. With publication no. WO/2026/035949, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAYDEN, Michael (c/o Prilenia Therapeutics Inc.300 Fifth Avenue, Suite 5010Waltham, 02451), GEVA, Michal (c/o Prilenia Therapeutics Inc.300 F...